Sarcoma

BOSTON, July 31, 2026 Ratio Therapeutics announced the successful closing of a $70 million Series C financing, increasing the...

CAMBRIDGE, UK, July 22, 2026 Healx, an AI-powered clinical-stage biotechnology company, has announced that the first patient has been...

LEXINGTON, Mass., July 17, 2026 Agenus Inc. announced that three investigator-sponsored studies evaluating its investigational botensilimab plus balstilimab (BOT+BAL)...

CAMBRIDGE, UK, May 22, 2026 STORM Therapeutics announced that new Phase 1 data for its first-in-class METTL3 inhibitor STC-15...